702689-96-1

Basic information

• Product Name: (S,S)-6-(4-amino-butyl)-1-biphenyl-4-ylmethyl-3-[4-(3-trifluoromethoxy-phenoxy)-benzyl]-piperazine-2,5-dione
• Synonyms: (S,S)-6-(4-amino-butyl)-1-biphenyl-4-ylmethyl-3-[4-(3-trifluoromethoxy-phenoxy)-benzyl]-piperazine-2,5-dione
• CAS NO: 702689-96-1
• Molecular Weight: 617.668
• Mol File: 702689-96-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S,S)-6-(4-amino-butyl)-1-biphenyl-4-ylmethyl-3-[4-(3-trifluoromethoxy-phenoxy)-benzyl]-piperazine-2,5-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (S,S)-6-(4-amino-butyl)-1-biphenyl-4-ylmethyl-3-[4-(3-trifluoromethoxy-phenoxy)-benzyl]-piperazine-2,5-dione(702689-96-1)
• EPA Substance Registry System: (S,S)-6-(4-amino-butyl)-1-biphenyl-4-ylmethyl-3-[4-(3-trifluoromethoxy-phenoxy)-benzyl]-piperazine-2,5-dione(702689-96-1)

Safety Data

• Hazardous Substances Data: 702689-96-1(Hazardous Substances Data)

Upstream product

• 179113-90-7 (3-(trifluoromethoxy)phenyl)boronic acid 

Relevant articles and documents

Compounds and compositions for treating obesity

Described herein are novel and useful compounds of the general formula Compounds of this invention can advantageously exhibit melanocortin receptor agonist activity. New and useful compounds comprising such a chemical structure and methods of modulating melanocortin receptor activity in a subject (and promoting, inducing, and/or enhancing the treatment or prevention of related diseases) by administering such a compound or composition also are described.